Back

Comparing the prevalence of cardiovascular inflammation in women and men with atherosclerotic cardiovascular disease with and without chronic kidney disease: a sub-analysis of the POSEIDON study

30 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Mechanism and risk assessment in peripheral artery disease Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Giovanna Liuzzo

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Additive prognostic impact of chronic kidney disease and heart failure in patients with lower extremity artery disease
Doctor K. Usami (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Panvascular burden in sepsis: anatomical risk saturation and physiological override
Mr H. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of zinc deficiency on clinical outcomes in patients with chronic limb-threatening ischemia following endovascular therapy
Doctor Y. Ikeuchi (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Glasgow prognostic score independently predicts amputation-free survival and wound healing in patients with chronic limb-threatening ischemia
Doctor J. Nakamura (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanism and risk assessment in peripheral artery disease

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of high inflammatory risk (hsCRP ≥2 mg/L) in European patients with atherosclerotic cardiovascular disease with/without chronic kidney disease: sub-analysis of the global POSEIDON study
31 August 2026
thumbnail
Congress Presentation
Sex differences in management of LDL-cholesterol in patients with chronic coronary syndrome
30 August 2024
thumbnail
Congress Presentation
Kidney function and future risk of atherosclerotic cardiovascular disease: a study from, approximately half million adults
25 August 2023
thumbnail
Congress Presentation
Assessing the cardiovascular toll of chronic inflammatory arthropathies: a case-control study on coronary artery disease severity
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources